These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30190822)

  • 1. The role of chemotherapy in the modern management of melanoma.
    Lee RJ; Ul-Ain-Tariq N; Fusi A; Bowyer S; Lorigan P
    Melanoma Manag; 2014 Nov; 1(2):173-184. PubMed ID: 30190822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role for chemotherapy in the modern management of melanoma.
    Gupta A; Gomes F; Lorigan P
    Melanoma Manag; 2017 May; 4(2):125-136. PubMed ID: 30190915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future roles of targeted therapy and immunotherapy in advanced melanoma.
    Olszanski AJ
    J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Treatments for Advanced Resectable Melanoma.
    Liu JY; Lowe M
    J Surg Oncol; 2019 Jan; 119(2):216-221. PubMed ID: 30589079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic malignant melanoma.
    Atallah E; Flaherty L
    Curr Treat Options Oncol; 2005 May; 6(3):185-93. PubMed ID: 15869730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma.
    Flaherty LE
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S15-20. PubMed ID: 10685653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for Melanoma.
    Wilson MA; Schuchter LM
    Cancer Treat Res; 2016; 167():209-29. PubMed ID: 26601864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma.
    Sood S; Jayachandiran R; Pandey S
    Integr Cancer Ther; 2021; 20():1534735421990078. PubMed ID: 33719631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemotherapy of melanoma.
    Flaherty LE; Gadgeel SM
    Semin Oncol; 2002 Oct; 29(5):446-55. PubMed ID: 12407509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in Melanoma: Recent Advances and Promising New Therapies.
    Saraceni MM; Khushalani NI; Jarkowski A
    J Pharm Pract; 2015 Apr; 28(2):193-203. PubMed ID: 24674910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of neoadjuvant therapy in advanced melanoma.
    Sun J; Kirichenko DA; Zager JS; Eroglu Z
    Melanoma Manag; 2019 Oct; 6(3):MMT27. PubMed ID: 31807278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for metastatic melanoma: time for a change?
    Gogas HJ; Kirkwood JM; Sondak VK
    Cancer; 2007 Feb; 109(3):455-64. PubMed ID: 17200963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for advanced melanoma: fulfilling the promise.
    Gogas H; Polyzos A; Kirkwood J
    Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma immunotherapy dominates the field.
    Diamantopoulos P; Gogas H
    Ann Transl Med; 2016 Jul; 4(14):269. PubMed ID: 27563656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
    Legha SS; Ring S; Eton O; Bedikian A; Plager C; Papadopoulos N
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S9-15. PubMed ID: 9457387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
    Anderson CM; Buzaid AC; Sussman J; Lee JJ; Ali-Osman F; Braunschweiger PG; Plager C; Bedikian A; Papadopoulos N; Eton O; Legha SS; Grimm EA
    Melanoma Res; 1998 Apr; 8(2):149-55. PubMed ID: 9610868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging targeted therapies for melanoma.
    Johnson DB; Pollack MH; Sosman JA
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):195-207. PubMed ID: 27148822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemotherapy for melanoma.
    Philip PA; Flaherty LE
    Curr Oncol Rep; 2000 Jul; 2(4):314-21. PubMed ID: 11122859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.